MAYRA VELAZQUEZ: Open Payments
NPI 1558632471 · HESPERIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 32 payments from 9 companies in 2025. Trend: 2023 $999 · 2024 $822 · 2025 $652
Food & beverage: $652
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $179 |
| Amgen Inc. | 7 | $146 |
| Novo Nordisk Inc | 5 | $105 |
| United Therapeutics Corporation | 2 | $60 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $56 |
| PFIZER INC. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: Repatha, WINREVAIR, Rybelsus, VERQUVO, Tyvaso, LEQVIO, LifeVest, Ozempic.
Industry payments across CA — which companies pay providers there.
